news
New Dietary Supplement Bill Could Redefine 'Drug'
The proposed Dietary Supplement Innovation Act aims to clarify the FDA's definition of a 'drug,' specifically regarding supplements already on the market before new drug applications. This legal shift could protect existing supplement ingredients from being reclassified as drugs, ensuring continued consumer access to compounds that support various body systems.
The proposed Dietary Supplement Innovation Act aims to clarify the FDA's definition of a 'drug,' specifically regarding supplements already on the market before new drug applications. This legal shift could protect existing supplement ingredients from being reclassified as drugs, ensuring continued consumer access to compounds that support various body systems.
The architecture take
The FDA's drug preclusion clause has been a pain for supplement brands trying to innovate, especially when a natural compound gets studied and then — boom — it's suddenly a 'drug.' This new Dietary Supplement Innovation Act wants to draw a clear line: if an ingredient was sold as a supplement before it got investigated as a drug, it stays a supplement. I see this as a move to shield ingredients like NAC from future regulatory headaches. It's less about new science and more about fixing an absurd legal loophole that hurts consumer access. What I'm watching is how it plays out for things that are right on the edge, like certain nootropics or hormone precursors. It's a fight over territory, really, defining what gets regulated how, and it's going to decide which compounds you can buy off the shelf for gut health or focus, and which end up needing a prescription.